10:16 AM EST - Oncolytics Biotech Inc. : Today announced the appointment of Jared Kelly as Chief Executive Officer and a member of its Board of Directors. Kelly is a successful biotech executive who has proven expertise in transformative deals and corporate strategy. Most recently, he played a central role in orchestrating the sale of Ambrx Biopharma to Johnson & Johnson for $2 billion. Oncolytics Biotech Inc.
shares T.ONC are trading up $0.07 at $0.64.
